The global laboratory centrifuge market size was valued at USD 1.8 Billion in 2024, and it is expected to reach USD 2.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.68% from 2025 to 2033.
To get more information on this market, Request Sample
One primary trend in the global laboratory centrifuge market is the growing shift toward automated and advanced models that enhance efficiency and accuracy. Labs are increasingly opting for centrifuges with features like digital controls, integration with lab management systems, and real-time data tracking. For instance, in February 2024, Thermo Fisher Scientific partnered with Multiply Labs to integrate robotic technology into its cell therapy instruments, including the Heracell VIOS CO2 Incubator and CTS Rotea Counterflow Centrifugation System. This collaboration enables full automation of cell therapy manufacturing, reducing costs, accelerating production, improving scalability, and optimizing space efficiency. Moreover, these innovations help reduce human error, improve precision, and speed up sample processing., thereby propelling the market growth. There's also a rising demand for centrifuges tailored for specific applications in fields like clinical diagnostics and biotechnology, where higher throughput and customization are crucial. This move towards automation reflects the need for greater productivity and accuracy in research, diagnostics, and quality control processes which solidify the biotechnology sector.
Another significant driver of the global centrifuge market is the growing emphasis on research and development in the pharmaceutical and biotechnology sectors. For instance, in November 2024, Johnson & Johnson, a global health care and medtech company based in New Jersey, announced its plans to invest over USD 2 billion in constructing a new biologics production facility in Wilson. As these industries advance, there is an increased need for precise and efficient sample separation technologies to support drug development, clinical trials, and molecular research. Centrifuges play a crucial role in processes like cell separation, protein analysis, and DNA extraction, which are essential for scientific advancements. Additionally, the rise in personalized medicine and biologics production further fuels demand for high-performance centrifuge models that can handle complex and diverse samples, driving innovation and growth in the market.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of robust technological advances, comprising research institutes and creative businesses.
North America is the leading region in the global laboratory centrifuge market, driven by significant investments in healthcare, research, and biotechnology sectors. For instance, in September 2024, the Health Resources and Services Administration (HRSA), part of the U.S. Department of Health and Human Services, announced investment of nearly USD 75 million to enhance healthcare in rural America. The funding will support opioid treatment services, maternal health care, and assist rural hospitals in staying open. The region's well-established pharmaceutical and medical industries are major consumers of laboratory centrifuges, which are essential for various diagnostic and research applications. Additionally, the growing focus on personalized medicine, clinical diagnostics, and biopharmaceutical research further propels market demand. Technological advancements and the presence of key market players in North America acts as another important factor to the region's dominant position, ensuring a steady supply of innovative centrifuge solutions for laboratories across diverse sectors.
The Asia Pacific region is experiencing rapid growth in the global laboratory centrifuge market, driven by increasing investments in healthcare and research. Escalating biopharmaceutical industries coupled with rising demand for clinical diagnostics, and advancements in medical research technology contribute to the region's strong market potential and future growth.
Europe remains prominent for the global laboratory centrifuge market, bolstered by strong healthcare infrastructure and research initiatives. Technological advancements in clinical diagnostics, pharmaceutical research, and biotechnology, further boosting the region’s demand for centrifuges market. Moreover, rising investments are major contributor in enhancement of medical laboratories and research facilities across various sectors.
Latin America is experiencing steady growth in the global laboratory centrifuge market, driven by increased investments in healthcare and research infrastructure. The demand is fueled by advancements in clinical diagnostics, pharmaceuticals, and biotechnology, as well as a growing focus on improving healthcare systems and laboratory capabilities across the region.
MEA is also experiencing growth in the global laboratory centrifuge market, principally because of the rising investments in medical research. Technological innovation particularly in clinical diagnostics and the biological and pharmacological industry together with progression in the medical technology field has expanded the use of centrifuges in the region, while improvements in the government support for these instruments in the region has also boosted the use of centrifuges and its corresponding market in circulation.
Some of the leading laboratory centrifuge market companies include Andreas Hettich GmbH & Co. KG, Becton, Dickinson and Company, Danaher Corporation, Eppendorf AG, GTCR LLC, HERMLE Labortechnik, Koki Holdings Co. Ltd., Kubota Corporation, NuAire, QIAGEN N.V., Sanofi Pasteur, Sartorius, Sigma Laborzentrifugen GmbH, Thermo Fisher Scientific Inc., among many others. In June 2024, Eppendorf partnered with NSG BioLabs, Singapore's largest provider of biotech co-working space. This collaboration will support biotech startups by offering resources such as product expertise, application guidance, and access to Eppendorf’s network, helping to advance research and development efforts.
Report Features | Details |
---|---|
Market Size in 2024 | USD 1.8 Billion |
Market Forecast in 2033 | USD 2.5 Billion |
Market Growth Rate (2025-2033) | 3.68% |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered |
|
Model Types Covered | Benchtop Centrifuges, Floor-Standing Centrifuges |
Rotor Designs Covered | Fixed-Angle Rotors, Swinging-Bucket Rotors, Vertical Rotors, Others |
Intended Uses Covered | General Purpose Centrifuges, Clinical Centrifuges, Preclinical Centrifuges |
Applications Covered | Diagnostics, Microbiology, Cellomics, Genomics, Proteomics, Blood Component Separation, Others |
End-Users Covered | Hospitals, Biotechnology and Pharmaceutical Company, Academic and Research Institutions |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Andreas Hettich GmbH & Co. KG, Becton, Danaher Corporation, Eppendorf AG, GTCR LLC, HERMLE Labortechnik, Koki Holdings Co. Ltd., Kubota Corporation, NuAire, QIAGEN N.V., Sanofi Pasteur, Sartorius, Sigma Laborzentrifugen GmbH, Thermo Fisher Scientific Inc., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |